Hans-Christian Kolberg, MD, Marien Hospital Bottrop, Bottrop, Germany outlines key highlights from the virtual 17th St. Gallen International Breast Cancer Consensus session on the optimal treatment of women with early breast cancer, including how the results of the ADAPT trial (NCT01779206) will influence risk assessment of HR+ breast cancer patients. This interview took place during the 17th St. Gallen International Breast Cancer Conference.